Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

Journal of Clinical Oncology

Volumn 19, Issue 2, 2001, Pages 376-388

  Olsen, E ^a   Duvic, M ^a   Frankel, A ^a   Kim, Y ^a   Martin, A ^a   Vonderheid, E ^a   Jegasothy, B ^a   Wood, G ^a   Gordon, M ^a   Heald, P ^a   Oseroff, A ^a   Pinter Brown, L ^a   Bowen, G ^a   Kuzel, T ^a   Fivenson, D ^a   Foss, F ^a   Glode, M ^a   Molina, A ^a   Knobler, E ^a   Stewart, S ^a   Cooper, K ^a   Stevens, S ^a   Craig, F ^a   Reuben, J ^a   Bacha, P ^a   Nichols, J ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; DENILEUKIN DIFTITOX;

ANTIBODY DETECTION; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DYSPNEA; FEMALE; FLU LIKE SYNDROME; HUMAN; HYPOTENSION; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN LYMPHOMA; T CELL LYMPHOMA; THORAX PAIN; TREATMENT OUTCOME;

EID: 0035863468     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.2.376     Document Type: Article

References (16)

1. Mycosis fungoides and the Sézary syndrome: Pathology, staging and treatment
2. The immunopathology of cutaneous lymphomas: Immunophenotypic and immunogenotypic characteristics
3. Report of the committee on staging and classification of CTCL
4. Staging and survival of cancer
5. 486IL-2): Fragment B sequences required for the delivery of fragment A to the cytosol of target cells
6. Interleukin-2 receptor-targeted cytotoxicity
7. The IL-2/IL-2 receptor system: A current overview
8. Internalization of interleukin-2 is mediated by the gamma chain of the high-affinity interleukin-2 receptor
9. Interleukin-2 receptor gamma chain expression on resting and activated lymphoid cells
10. Differential expression of interleukin-2 receptors (alpha and beta chain) in mature lymphoid neoplasms
11. Interleukin-2 receptor-targeted cytotoxicity: Receptor binding requirements for entry of a diphtheria toxin-related interleukin-2 fusion protein into cells
12. 389IL-2) in lymphomas expressing the receptor for interleukin-2
13. 389IL-2 fusion toxin in mycosis fungoides
14. Histologic assessment of lymph nodes in mycosis fungoides/sezary syndrome (cutaneous T-cell lymphoma): Clinical correlations and prognostic import of a new classification system
15. Comparison of two devices for wound measurement
16. Grading of the severity of atopic dermatitis